A meta-analysis of trials comparing ACE inhibitors alone or in combination with ARBs in patients with LVD or HF showed an increased risk of developing any AE, hypotension, worsening renal function and hyperkalaemia with combination therapy, suggesting ACE inhibitors should not be routinely used in combination with ARBs in patients with LVD [76]. The gene discussed is ACE; the disease is hydrops fetalis.